A Novel FUS/CHOP Chimera in Myxoid Liposarcoma

This publication has 30 references indexed in Scilit:

• A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells
  Oncogene, 1999
• Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation
  Oncogene, 1999
• Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation
  Oncogene, 1999
• Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia
  Oncogene, 1997
• Cloning and Mapping of a HumanRBP56Gene Encoding a Putative RNA Binding Protein Similar to FUS/TLS and EWS Proteins
  Genomics, 1996
• Expression Patterns of the Human Sarcoma-Associated GenesFUSandEWSand the Genomic Structure ofFUS
  Genomics, 1996
• A novel gene, Translin, encodes a recombination hotspot binding protein associated with chromosomal translocations
  Nature Genetics, 1995
• A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP.
  Genes & Development, 1994
• Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma
  Nature Genetics, 1993
• Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
  Nature, 1993